ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 458 out of 3001

$656K Total Retail Price of All Prescriptions

Rank: 339 out of 3001

336 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 7,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 348 217 S3 1 7
LEVOTHYROXINE SODIUM 321 230 2 3
SIMVASTATIN 311 254 3 1
LISINOPRIL 285 235 4 2
CARVEDILOL 268 253 5 25
METFORMIN HCL 214 167 6 9
CEPHALEXIN 204 161 7 86
LISINOPRIL-HYDROCHLOROTHIAZIDE 199 155 8 22
ATORVASTATIN CALCIUM 199 171 8 11
FUROSEMIDE 149 105 10 6
WARFARIN SODIUM 147 135 11 12
VERAPAMIL HCL 135 110 12 370
CRESTOR 132 106 13 33
CIPROFLOXACIN HCL 131 103 14 56
MELOXICAM 125 93 15 34
ALENDRONATE SODIUM 123 109 16 26
AMLODIPINE BESYLATE 121 110 17 5
TRAMADOL HCL 117 84 18 17
DOXAZOSIN MESYLATE 117 97 18 90
METOPROLOL TARTRATE 116 97 20 8
RANITIDINE HCL 114 79 21 41
CLOPIDOGREL 112 98 22 28
OMEPRAZOLE 110 81 23 4
NEXIUM 106 67 24 23
PREDNISONE 106 86 24 39
TRILIPIX 105 85 26 193
FENTANYL 104 49 S2 27 76
AMITRIPTYLINE HCL 101 46 R 28 85
CYMBALTA 100 62 29 53
HYDROCHLOROTHIAZIDE 99 70 30 10
VERAPAMIL ER 94 87 31 102
GABAPENTIN 93 51 32 14
METOLAZONE 88 82 33 198
SINGULAIR 87 65 34 95
GLIPIZIDE 86 84 35 67
CITALOPRAM HBR 85 66 36 16
PLAVIX 75 70 37 46
POTASSIUM CHLORIDE 74 64 38 15
ATENOLOL 73 61 39 18
QUETIAPINE FUMARATE 66 40 40 66
CYCLOBENZAPRINE HCL 65 37 R 41 73
OXYCODONE HCL-ACETAMINOPHEN 65 17 S2 41 81
PROAIR HFA 64 36 43 30
CLONIDINE HCL 63 62 44 64
DICYCLOMINE HCL 62 46 45 202
CELEBREX 60 56 46 89
SPIRIVA 58 44 47 57
SERTRALINE HCL 57 35 48 20
ADVAIR DISKUS 54 28 49 58
EVISTA 54 54 49 148
CILOSTAZOL 54 48 49 224
PHENYTOIN SODIUM EXTENDED 54 11 49 126
TAMSULOSIN HCL 53 44 53 29
DIGOXIN 50 50 54 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.